Nordic Countries Join Race To Withdraw OTC Ranitidine
OTC presentations of ranitidine have been pulled from shelves in Denmark, Finland and Norway after the European Medicines Agency launched a review into the drug over safety fears.
You may also be interested in...
Concerns over the presence of a probable human carcinogen will likely see marketing of all ranitidine-containing drugs suspended across the European Union.
Following the US request for ranitidine drugs to be withdrawn from the market, the European Medicines Agency says it would decide the fate of the products in the EU after wrapping up its own inquiry.
As ranitidine suspensions and recalls mount worldwide, US agency says heat of pharmacy lab's test made nitrosamine levels appear high.